# NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases

> **NCT01370213** · PHASE2 · COMPLETED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 25 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Preparative Regimen
- **BIOLOGICAL:** NK Cells
- **DRUG:** Interleukin-2
- **BIOLOGICAL:** CD34 Graft/Anti-thymocyte globulin
- **BIOLOGICAL:** Donor TCR α/β-depleted Graft/ATG

## Key facts

- **NCT ID:** NCT01370213
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2016-04
- **Final completion:** 2017-04
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01370213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01370213, "NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01370213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*